期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | PHARMACEUTICAL STATISTICS LetPub Score 5.0
50 ratings
Rate
Reputation 6.3 Influence 3.6 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | PHARM STAT | ||||||||||||||||||||||||
ISSN | 1539-1604 | ||||||||||||||||||||||||
E-ISSN | 1539-1612 | ||||||||||||||||||||||||
h-index | 33 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 7.70%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1539-1612 | ||||||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/pst-wiley | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | John Wiley and Sons Ltd | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||
創刊年 | 2002 | ||||||||||||||||||||||||
每年文章數 | 63每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 14.41% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1539-1604%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[PHARMACEUTICAL STATISTICS] 的評論 | 撰寫評論 |
作者: 宗室志涛 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-17 13:10:07 評論於 Review Speed: 6.0 | Submission Hit Rate: 50.0 Emphasized Research Direction: Statistical methods; Experience in Biostatistics: Submitted in September 22, reviewed by two reviewers, received comments in November, revised once, accepted in January 23(0) 讚! | 宗室志涛 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 12:04:47 評論於 Research Background: In recent years, the study of XX has gained increasing attention due to its potential applications in various fields. The development status of XX has also advanced significantly, with many research breakthroughs being made. Research Significance: Understanding XX is crucial for the advancement of technology and innovation in XX-related industries. Furthermore, the study of XX can provide valuable insights into XX-related phenomena, leading to potential solutions for existing problems. Research Development: Despite the progress made in the study of XX, there are still unresolved issues and challenges that need to be addressed. This motivates me to conduct further research in this area to contribute to the existing knowledge and potentially find new solutions to these challenges. Research Purpose: The specific objective of my research is to investigate the XX phenomenon in depth and explore its potential applications in various industries. By gaining a deeper understanding of XX, I aim to contribute to the advancement of technology and innovation in this field(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:06:34 評論於 Important documents, if available, can be used to provide evidence, but they may show different emphasis(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 20:11:03 評論於 Is the important literature in the results or described in the introduction?(0) 讚! | 魂魄彦露 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 12:26:51 評論於 What does the three-point introduction refer to?(0) 讚! | 魂魄彦露 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us